Please login to the form below

Not currently logged in
Email:
Password:

Aerie Pharmaceuticals appoints new members of its commercialisation team

David Biddell, Shaun Gentry and Erin Horn join the firm

Eye-disease focused pharmaceutical company Aerie Pharmaceuticals has appointed a trio of new comers to its commercialisation team.

David Biddell joins the US group as its regional sales director for the southeast region, reporting to Gary Menichini who is currently vice president of sales.

Meanwhile, Shaun Gentry and Erin Horn both join from Novartis as directors of national accounts in the market access group.

They will both report to Dale Seibt, who is vice president of market access for North Carolina-based Aerie.

28th November 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....

Infographics